Recombinant human superoxide dismutase enhances the effect of inhaled nitric oxide in persistent pulmonary hypertension.

We investigated the pulmonary vascular effects of superoxide dismutase (SOD) alone and in combination with inhaled nitric oxide (iNO) in newborn lambs with persistent pulmonary hypertension (PPHN) following prenatal ligation of the ductus arteriosus. In in vitro experiments, pretreatment with SOD significantly enhanced vascular relaxation in response to the NO donor S-nitrosyl-acetylpenicillamine (SNAP) in fifth-generation pulmonary arteries isolated from lambs with PPHN. In vivo treatment of fully instrumented newborn lambs with a single intratracheal dose of recombinant human CuZn SOD (rhSOD; 5 mg/kg) produced selective dilation of the pulmonary circulation. Further studies, of the combination of rhSOD and iNO, showed enhancement of the pulmonary vascular effects of iNO after brief periods of inhalation of 5 ppm and 80 ppm NO. We conclude that rhSOD reduces pulmonary vascular resistance and facilitates the action of iNO in a lamb model of PPHN. This suggests that rhSOD may prove to be an effective adjunctive treatment for newborns with PPHN.

[1]  J. Russell,et al.  Pulmonary hypertension alters soluble guanylate cyclase activity and expression in pulmonary arteries isolated from fetal lambs , 2001, Pediatric pulmonology.

[2]  J. T. O'neill,et al.  Superoxide Dismutase and Catalase Do Not Affect the Pulmonary Hypertensive Response to Group B Streptococcus in the Lamb , 2001, Pediatric Research.

[3]  M. Keszler,et al.  Low-dose nitric oxide therapy for persistent pulmonary hypertension of the newborn. Clinical Inhaled Nitric Oxide Research Group. , 2000, The New England journal of medicine.

[4]  J. Russell,et al.  The cGMP-specific phosphodiesterase inhibitor E4021 dilates the pulmonary circulation. , 1999, American journal of respiratory and critical care medicine.

[5]  J. Davis,et al.  Improved pulmonary distribution of recombinant human Cu/Zn superoxide dismutase, using a modified ultrasonic nebulizer , 1999, Pediatric pulmonology.

[6]  J. Russell,et al.  Pulmonary and Systemic Effects of the Phosphodiesterase Inhibitor Dipyridamole in Newborn Lambs with Persistent Pulmonary Hypertension , 1998, Pediatric Research.

[7]  A. Koller,et al.  Superoxide released to high intra-arteriolar pressure reduces nitric oxide-mediated shear stress- and agonist-induced dilations. , 1998, Circulation research.

[8]  G. Schultz,et al.  Stimulation of soluble guanylate cyclase by superoxide dismutase is mediated by NO. , 1998, The Biochemical journal.

[9]  B. Mayer,et al.  A New Pathway of Nitric Oxide/Cyclic GMP Signaling InvolvingS-Nitrosoglutathione* , 1998, The Journal of Biological Chemistry.

[10]  W. Zapol,et al.  Cyclic-GMP-Binding, Cyclic-GMP-Specific Phosphodiesterase (PDE5) Gene Expression Is Regulated during Rat Pulmonary Development , 1998, Pediatric Research.

[11]  W. Carlo,et al.  Safety and pharmacokinetics of multiple doses of recombinant human CuZn superoxide dismutase administered intratracheally to premature neonates with respiratory distress syndrome. , 1997, Pediatrics.

[12]  Jesse D. Roberts,et al.  Inhaled Nitric Oxide and Persistent Pulmonary Hypertension of the Newborn , 1997 .

[13]  J. Davis,et al.  Safety and pharmacokinetics of recombinant human superoxide dismutase administered intratracheally to premature neonates with respiratory distress syndrome. , 1996, Pediatrics.

[14]  J. Russell,et al.  The cGMP phosphodiesterase inhibitor zaprinast enhances the effect of nitric oxide. , 1995, American journal of respiratory and critical care medicine.

[15]  S. Soifer,et al.  Chronic nitric oxide inhibition in utero produces persistent pulmonary hypertension in newborn lambs. , 1994, The Journal of clinical investigation.

[16]  Jesse D. Roberts,et al.  Effect of nitric oxide on the survival rate and incidence of lung injury in newborn lambs with persistent pulmonary hypertension. , 1993, The Journal of pediatrics.

[17]  F. Morin,et al.  Treatment of persistent pulmonary hypertension in the newborn lamb by inhaled nitric oxide. , 1993, The Journal of pediatrics.

[18]  Susan E. Brown,et al.  The Effect of Hyperoxic Exposure on Antioxidant Enzyme Activities of Alveolar Type II Cells in Neonatal and Adult Rats , 1992, Pediatric Research.

[19]  F. Accurso,et al.  Failure of postnatal adaptation of the pulmonary circulation after chronic intrauterine pulmonary hypertension in fetal lambs. , 1989, The Journal of clinical investigation.

[20]  F. C. Morin.  Ligating the Ductus Arteriosus before Birth Causes Persistent Pulmonary Hypertension in the Newborn Lamb , 1989, Pediatric Research.

[21]  L. Wild,et al.  Ligating the Ductus Arteriosus before birth Remodels the Pulmonary Vasculature of the Lamb , 1989, Pediatric Research.

[22]  J. Murphy,et al.  The structural basis of persistent pulmonary hypertension of the newborn infant. , 1981, The Journal of pediatrics.